Home > International Stem Cell Corp. ISCO > Page 2

Tag: International Stem Cell Corp. ISCO

TuesdayMay 15, 2012 9:11 am

International Stem Cell Corp. (ISCO) Scientists to Attend Gene and Cell Therapy Meeting in Philadelphia and Present Pre-Clinical Research Results

International Stem Cell Corp. this morning announced that several of its leading scientists will be presenting experimental results from three of ISCO’s pre-clinical therapeutic programs at the 15th Annual Meeting of American Society of Gene and Cell Therapy, in Philadelphia at 3:30 p.m. on Thursday, May 17th. Firstly, the application of A9 dopaminergic neurons derived from human parthenogenetic stem cells (hpSC) for the treatment of Parkinson’s disease. Demonstrating functional dopaminergic neurons in vivo represents an important milestone towards the goal of creating well characterized populations of cells that could be used to develop a treatment for Parkinson’s. Secondly, the differentiation…

Continue Reading

MondayMay 14, 2012 10:17 am

International Stem Cell Corp. (ISCO) Video Chart for Monday, May 14, 2012

ISCO has formed a triple bottom pattern with support at 40 cents. There is more support down at 34 cents, but the 40 cent mark has produced two bounces in excess of 50 percent (to $0.68 and $0.65) in the last five months. Technical traders will be watching closely for the pattern to repeat. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts: International Stem Cell Corp. Message Board

Continue Reading

FridayMay 11, 2012 8:44 am

International Stem Cell Corp. (ISCO) is “One to Watch”

International Stem Cell Corp. specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation. hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of…

Continue Reading

ThursdayMay 10, 2012 2:21 pm

International Stem Cell Corp. (ISCO) Announces New Stem Cell Manufacturing Technologies

International Stem Cell Corp., developer of therapeutic applications of human parthenogenetic stem cells (hpSCs) and cell-based research and cosmetic products, announced today that they have developed new technologies to commercialize the use of human parthenogenetic stem cells to treat human diseases. The methods announced are able to produce populations of stem cells, in addition to their therapeutically valuable derivatives, at a higher level of purity and at a cost that is several times lower than previously reported techniques. Specifically, the company’s research team has developed a new method of generating high-purity populations of neural stem cells from hpSC, and then…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .